Takeda (TSE:4502/NYSE:TAK) today announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombinant Human ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
The Indian rupee's 2.34% depreciation against the US dollar from December 2023 to December 2024 is expected to increase India's import bill by about USD 15 billion. Gold and industrial goods imports ...